Search research articles
Contact Us
Filters
Showing results (791-800 of 13,985) with videos related to
Page
of 1,399
Sort By:
Leukemia
|
June 4, 2010
Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism
R A Hamoudi, A Appert, H Ye, et al.
Leukemia
|
June 4, 2010
Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells
J-J Kiladjian, A Massé, B Cassinat, et al.
Leukemia
|
July 1, 1991
Chronic myelomonocytic leukemia transformation in polycythemia vera
R F Holcombe, P A Treseler, D S Rosenthal
Leukemia
|
July 1, 1991
Chronic myelocytic leukaemia with unusual (27 years) complete remission terminating in acute undifferentiated leukaemia: a clinical and karyotypic study
Y Najean, M Miclea, J Tanzer, et al.
Leukemia
|
July 1, 1991
Curing leukemia
R P Gale, J V Simone, D Hoelzer, et al.
Leukemia
|
August 27, 2010
Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q)
C Chen, D T Bowen, A A N Giagounidis, et al.
Leukemia
|
August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
M A Dimopoulos, E Kastritis, D Christoulas, et al.
Leukemia
|
August 21, 2010
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
H Makishima, A M Jankowska, R V Tiu, et al.
Leukemia
|
August 21, 2010
Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide
S Park, D Vassilieff, V Bardet, et al.
Leukemia
|
June 11, 2010
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Thomas Bumm, Jutta Deininger, Amy Hanlon Newell, et al.
Page
of 1,399
Search research articles
Search
Showing results (791-800 of 13,985) with videos related to
Sort By:
Page
of 1,399
Leukemia
|
June 4, 2010
Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism
R A Hamoudi, A Appert, H Ye, et al.
Leukemia
|
June 4, 2010
Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells
J-J Kiladjian, A Massé, B Cassinat, et al.
Leukemia
|
July 1, 1991
Chronic myelomonocytic leukemia transformation in polycythemia vera
R F Holcombe, P A Treseler, D S Rosenthal
Leukemia
|
July 1, 1991
Chronic myelocytic leukaemia with unusual (27 years) complete remission terminating in acute undifferentiated leukaemia: a clinical and karyotypic study
Y Najean, M Miclea, J Tanzer, et al.
Leukemia
|
July 1, 1991
Curing leukemia
R P Gale, J V Simone, D Hoelzer, et al.
Leukemia
|
August 27, 2010
Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q)
C Chen, D T Bowen, A A N Giagounidis, et al.
Leukemia
|
August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
M A Dimopoulos, E Kastritis, D Christoulas, et al.
Leukemia
|
August 21, 2010
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
H Makishima, A M Jankowska, R V Tiu, et al.
Leukemia
|
August 21, 2010
Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide
S Park, D Vassilieff, V Bardet, et al.
Leukemia
|
June 11, 2010
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Thomas Bumm, Jutta Deininger, Amy Hanlon Newell, et al.
Page
of 1,399